Medicamen Biotech Limited (MEDICAMEQ) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.045x

Based on the latest financial reports, Medicamen Biotech Limited (MEDICAMEQ) has a cash flow conversion efficiency ratio of -0.045x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-124.06 Million ≈ $-1.34 Million USD) by net assets (Rs2.75 Billion ≈ $29.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see MEDICAMEQ stock market capitalisation for the company's overall valuation and market capitalisation.

Medicamen Biotech Limited - Cash Flow Conversion Efficiency Trend (2006–2026)

This chart illustrates how Medicamen Biotech Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Medicamen Biotech Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medicamen Biotech Limited ranked by their cash flow conversion efficiency. Explore Medicamen Biotech Limited (MEDICAMEQ) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
HLV LIMITED
NSE:HLVLTD
0.007x
Wästbygg Gruppen AB (publ)
ST:WBGR-B
-0.225x
Elinoil Hellenic Petroleum Company S.A
AT:ELIN
0.505x
Agile Content SA
MC:AGIL
-0.035x
Lesico Ltd
TA:LSCO
0.226x
Ckd Bio
KO:063160
0.022x
Promateris SA
RO:PPL
N/A
W S Industries (I) Limited
NSE:WSI
0.030x

Annual Cash Flow Conversion Efficiency for Medicamen Biotech Limited (2006–2026)

The table below shows the annual cash flow conversion efficiency of Medicamen Biotech Limited from 2006 to 2026. View Medicamen Biotech Limited stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs2.76 Billion
≈ $29.80 Million
Rs-349.31 Million
≈ $-3.78 Million
-0.127x -173.60%
2025-03-31 Rs2.13 Billion
≈ $23.01 Million
Rs-98.59 Million
≈ $-1.07 Million
-0.046x -42.21%
2024-03-31 Rs2.07 Billion
≈ $22.38 Million
Rs-67.44 Million
≈ $-729.32K
-0.033x -0.14%
2023-03-31 Rs1.93 Billion
≈ $20.92 Million
Rs-62.93 Million
≈ $-680.54K
-0.033x -215.97%
2022-03-31 Rs1.46 Billion
≈ $15.84 Million
Rs41.09 Million
≈ $444.38K
0.028x -70.81%
2021-03-31 Rs1.33 Billion
≈ $14.37 Million
Rs127.72 Million
≈ $1.38 Million
0.096x -9.00%
2020-03-31 Rs1.21 Billion
≈ $13.11 Million
Rs128.02 Million
≈ $1.38 Million
0.106x +112.74%
2019-03-31 Rs866.34 Million
≈ $9.37 Million
Rs43.01 Million
≈ $465.12K
0.050x +167.91%
2018-03-31 Rs746.08 Million
≈ $8.07 Million
Rs-54.54 Million
≈ $-589.80K
-0.073x -154.50%
2017-03-31 Rs267.81 Million
≈ $2.90 Million
Rs35.92 Million
≈ $388.49K
0.134x -61.29%
2016-03-31 Rs179.09 Million
≈ $1.94 Million
Rs62.06 Million
≈ $671.13K
0.347x +281.86%
2015-03-31 Rs171.85 Million
≈ $1.86 Million
Rs-32.74 Million
≈ $-354.11K
-0.191x -161.32%
2014-03-31 Rs165.38 Million
≈ $1.79 Million
Rs51.39 Million
≈ $555.74K
0.311x +410.42%
2013-03-31 Rs157.17 Million
≈ $1.70 Million
Rs-15.73 Million
≈ $-170.14K
-0.100x +42.34%
2012-03-31 Rs201.01 Million
≈ $2.17 Million
Rs-34.90 Million
≈ $-377.38K
-0.174x -131.21%
2011-03-31 Rs204.12 Million
≈ $2.21 Million
Rs113.52 Million
≈ $1.23 Million
0.556x +722.44%
2010-03-31 Rs162.61 Million
≈ $1.76 Million
Rs11.00 Million
≈ $118.92K
0.068x -89.45%
2009-03-31 Rs129.60 Million
≈ $1.40 Million
Rs83.07 Million
≈ $898.33K
0.641x +227.09%
2008-03-31 Rs115.83 Million
≈ $1.25 Million
Rs22.70 Million
≈ $245.46K
0.196x +662.67%
2007-03-31 Rs100.73 Million
≈ $1.09 Million
Rs2.59 Million
≈ $27.99K
0.026x -91.54%
2006-03-31 Rs85.67 Million
≈ $926.49K
Rs26.02 Million
≈ $281.45K
0.304x --

About Medicamen Biotech Limited

NSE:MEDICAMEQ India Drug Manufacturers - Specialty & Generic
Market Cap
$48.12 Million
Rs4.45 Billion INR
Market Cap Rank
#22136 Global
#1222 in India
Share Price
Rs328.05
Change (1 day)
-5.27%
52-Week Range
Rs219.88 - Rs415.95
All Time High
Rs1195.88
About

Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, syrups, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-… Read more